{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T21:16:20Z","timestamp":1781817380090,"version":"3.54.5"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2006,6,23]],"date-time":"2006-06-23T00:00:00Z","timestamp":1151020800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genet"],"published-print":{"date-parts":[[2006,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Type 1 diabetes (T1D) is a chronic, autoimmune and multifactorial disease characterized by abnormal metabolism of carbohydrate and fat. Diminished carnitine plasma levels have been previously reported in T1D patients and carnitine increases the sensitivity of the cells to insulin. Polymorphisms in the carnitine transporters, encoded by the <jats:italic>SLC22A4<\/jats:italic> and <jats:italic>SLC22A5<\/jats:italic> genes, have been involved in susceptibility to two other autoimmune diseases, rheumatoid arthritis and Crohn's disease. For these reasons, we investigated for the first time the association with T1D of six single nucleotide polymorphisms (SNPs) mapping to these candidate genes: slc2F2, slc2F11, T306I, L503F, OCTN2-promoter and OCTN2-intron.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A case-control study was performed in the Spanish population with 295 T1D patients and 508 healthy control subjects. Maximum-likelihood haplotype frequencies were estimated by applying the Expectation-Maximization (EM) algorithm implemented by the Arlequin software.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>When independently analyzed, one of the tested polymorphisms in the <jats:italic>SLC22A4<\/jats:italic> gene at 1672 showed significant association with T1D in our Spanish cohort. The overall comparison of the inferred haplotypes was significantly different between patients and controls (\u03c7<jats:sup>2<\/jats:sup> = 10.43; p = 0.034) with one of the haplotypes showing a protective effect for T1D (rs3792876\/rs1050152\/rs2631367\/rs274559, CCGA: OR = 0.62 (0.41\u20130.93); p = 0.02).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The haplotype distribution in the carnitine transporter locus seems to be significantly different between T1D patients and controls; however, additional studies in independent populations would allow to confirm the role of these genes in T1D risk.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2350-7-54","type":"journal-article","created":{"date-parts":[[2006,6,23]],"date-time":"2006-06-23T18:34:29Z","timestamp":1151087669000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Evidence for the association of the SLC22A4 and SLC22A5 genes with Type 1 Diabetes: a case control study"],"prefix":"10.1186","volume":"7","author":[{"given":"Jose Luis","family":"Santiago","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermenegildo","family":"de la Calle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Fern\u00e1ndez-Arquero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M \u00c1ngeles","family":"Figueredo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio G","family":"de la Concha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Urcelay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,6,23]]},"reference":[{"key":"162_CR1","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/S0140-6736(74)91201-X","volume":"2","author":"J Nerup","year":"1974","unstructured":"Nerup J, Platz P, Andersen OO, Christy M, Lyngsoe J, Poulsen JE, Ryder LP, Nielsen LS, Thomsen M, Svejgaard A: HL-A antigens and diabetes mellitus. Lancet. 1974, 2: 864-866. 10.1016\/S0140-6736(74)91201-X.","journal-title":"Lancet"},{"key":"162_CR2","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/sj.gene.6363875","volume":"3","author":"F Pociot","year":"2002","unstructured":"Pociot F, McDermott MF: Genetics of type 1 diabetes mellitus. Genes Immun. 2002, 3: 235-249. 10.1038\/sj.gene.6363875.","journal-title":"Genes Immun"},{"key":"162_CR3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s125-002-8241-7","volume":"45","author":"LL Field","year":"2002","unstructured":"Field LL: Genetic linkage and association studies of Type I diabetes: challenges and rewards. Diabetologia. 2002, 45: 21-35. 10.1007\/s125-002-8241-7.","journal-title":"Diabetologia"},{"key":"162_CR4","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/371130a0","volume":"371","author":"JL Davies","year":"1994","unstructured":"Davies JL, Kawaguchi Y, Bennett ST, Copeman JB, Cordell HJ, Pritchard LE, Reed PW, Gough SC, Jenkins SC, Palmer SM, et al: A genome-wide search for human type 1 diabetes susceptibility genes. Nature. 1994, 371: 130-136. 10.1038\/371130a0.","journal-title":"Nature"},{"key":"162_CR5","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ymgme.2003.11.010","volume":"81","author":"S Anjos","year":"2004","unstructured":"Anjos S, Polychronakos C: Mechanisms of genetic susceptibility to type I diabetes: beyond HLA. Mol Genet Metab. 2004, 81: 187-195. 10.1016\/j.ymgme.2003.11.010.","journal-title":"Mol Genet Metab"},{"key":"162_CR6","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1042\/bst0280182","volume":"28","author":"RR Ramsay","year":"2000","unstructured":"Ramsay RR: The carnitine acyltransferases: modulators of acyl-CoA-dependent reactions. Biochem Soc Trans. 2000, 28: 182-186.","journal-title":"Biochem Soc Trans"},{"key":"162_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1196\/annals.1320.001","volume":"1033","author":"DW Foster","year":"2004","unstructured":"Foster DW: The role of the carnitine system in human metabolism. Ann N Y Acad Sci. 2004, 1033: 1-16. 10.1196\/annals.1320.001.","journal-title":"Ann N Y Acad Sci"},{"key":"162_CR8","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1007\/s004310050732","volume":"156","author":"F Proulx","year":"1997","unstructured":"Proulx F, Lacroix J, Qureshi IA, Nadeau D, Gauthier M, Lambert M: Acquired carnitine abnormalities in critically ill children. Eur J Pediatr. 1997, 156: 864-869. 10.1007\/s004310050732.","journal-title":"Eur J Pediatr"},{"key":"162_CR9","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1507\/endocrj1954.34.415","volume":"34","author":"Y Okuda","year":"1987","unstructured":"Okuda Y, Kawai K, Murayama Y, Yamashita K: Postprandial changes in plasma ketone body and carnitine levels in normal and non-insulin-dependent diabetic subjects. Endocrinol Jpn. 1987, 34: 415-422.","journal-title":"Endocrinol Jpn"},{"key":"162_CR10","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1007\/BF00184484","volume":"71","author":"P Pregant","year":"1993","unstructured":"Pregant P, Kaiser E, Schernthaner G: No effect of insulin treatment or glycemic improvement on plasma carnitine levels in type 2 diabetic patients. Clin Investig. 1993, 71: 610-612. 10.1007\/BF00184484.","journal-title":"Clin Investig"},{"key":"162_CR11","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S1056-8727(99)00052-5","volume":"13","author":"N Tamamogullari","year":"1999","unstructured":"Tamamogullari N, Silig Y, Icagasioglu S, Atalay A: Carnitine deficiency in diabetes mellitus complications. J Diabetes Complications. 1999, 13: 251-253. 10.1016\/S1056-8727(99)00052-5.","journal-title":"J Diabetes Complications"},{"key":"162_CR12","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/j.1651-2227.1983.tb09762.x","volume":"72","author":"G Soltesz","year":"1983","unstructured":"Soltesz G, Melegh B, Sandor A: The relationship between carnitine and ketone body levels in diabetic children. Acta Paediatr Scand. 1983, 72: 511-515.","journal-title":"Acta Paediatr Scand"},{"key":"162_CR13","first-page":"1337","volume":"143","author":"SC Winter","year":"1989","unstructured":"Winter SC, Simon M, Zorn EM, Szabo-Aczel S, Vance WH, O'Hara T, Higashi L: Relative carnitine insufficiency in children with type I diabetes mellitus. Am J Dis Child. 1989, 143: 1337-1339.","journal-title":"Am J Dis Child"},{"key":"162_CR14","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/BF01649287","volume":"69","author":"P Pregant","year":"1991","unstructured":"Pregant P, Schernthaner G, Legenstein E, Lienhart L, Bruck S, Schnack C, Kaiser E: [Decreased plasma carnitine in Type I diabetes mellitus]. Klin Wochenschr. 1991, 69: 511-516. 10.1007\/BF01649287.","journal-title":"Klin Wochenschr"},{"key":"162_CR15","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S1056-8727(03)00091-6","volume":"18","author":"D Mamoulakis","year":"2004","unstructured":"Mamoulakis D, Galanakis E, Dionyssopoulou E, Evangeliou A, Sbyrakis S: Carnitine deficiency in children and adolescents with type 1 diabetes. J Diabetes Complications. 2004, 18: 271-274. 10.1016\/S1056-8727(03)00091-6.","journal-title":"J Diabetes Complications"},{"key":"162_CR16","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1159\/000046752","volume":"46","author":"M Akisu","year":"2002","unstructured":"Akisu M, Kultursay N, Coker I, Huseyinov A: Myocardial and hepatic free carnitine concentrations in pups of diabetic female rats. Ann Nutr Metab. 2002, 46: 45-48. 10.1159\/000046752.","journal-title":"Ann Nutr Metab"},{"key":"162_CR17","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0014-5793(97)01441-5","volume":"419","author":"I Tamai","year":"1997","unstructured":"Tamai I, Yabuuchi H, Nezu J, Sai Y, Oku A, Shimane M, Tsuji A: Cloning and characterization of a novel human pH-dependent organic cation transporter, OCTN1. FEBS Lett. 1997, 419: 107-111. 10.1016\/S0014-5793(97)01441-5.","journal-title":"FEBS Lett"},{"key":"162_CR18","doi-asserted-by":"publisher","first-page":"5256","DOI":"10.1073\/pnas.0408624102","volume":"102","author":"D Grundemann","year":"2005","unstructured":"Grundemann D, Harlfinger S, Golz S, Geerts A, Lazar A, Berkels R, Jung N, Rubbert A, Schomig E: Discovery of the ergothioneine transporter. Proc Natl Acad Sci U S A. 2005, 102: 5256-5261. 10.1073\/pnas.0408624102.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"162_CR19","doi-asserted-by":"publisher","first-page":"20378","DOI":"10.1074\/jbc.273.32.20378","volume":"273","author":"I Tamai","year":"1998","unstructured":"Tamai I, Ohashi R, Nezu J, Yabuuchi H, Oku A, Shimane M, Sai Y, Tsuji A: Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2. J Biol Chem. 1998, 273: 20378-20382. 10.1074\/jbc.273.32.20378.","journal-title":"J Biol Chem"},{"key":"162_CR20","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/ng1267","volume":"35","author":"S Tokuhiro","year":"2003","unstructured":"Tokuhiro S, Yamada R, Chang X, Suzuki A, Kochi Y, Sawada T, Suzuki M, Nagasaki M, Ohtsuki M, Ono M, Furukawa H, Nagashima M, Yoshino S, Mabuchi A, Sekine A, Saito S, Takahashi A, Tsunoda T, Nakamura Y, Yamamoto K: An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis. Nat Genet. 2003, 35: 341-348. 10.1038\/ng1267.","journal-title":"Nat Genet"},{"key":"162_CR21","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/ng1339","volume":"36","author":"VD Peltekova","year":"2004","unstructured":"Peltekova VD, Wintle RF, Rubin LA, Amos CI, Huang Q, Gu X, Newman B, Van Oene M, Cescon D, Greenberg G, Griffiths AM, St George-Hyslop PH, Siminovitch KA: Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat Genet. 2004, 36: 471-475. 10.1038\/ng1339.","journal-title":"Nat Genet"},{"key":"162_CR22","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1471-2350-7-20","volume":"7","author":"DJ Smyth","year":"2006","unstructured":"Smyth DJ, Howson JM, Payne F, Maier LM, Bailey R, Holland K, Lowe CE, Cooper JD, Hulme JS, Vella A, Dahlman I, Lam AC, Nutland S, Walker NM, Twells RC, Todd JA: Analysis of polymorphisms in 16 genes in type 1 diabetes that have been associated with other immune-mediated diseases. BMC Med Genet. 2006, 7: 20-10.1186\/1471-2350-7-20.","journal-title":"BMC Med Genet"},{"key":"162_CR23","volume-title":"Arlequin: A Software for Population Genetics Data Analysis","author":"DRLE Stefan Schneider","year":"2000","unstructured":"Stefan Schneider DRLE: Arlequin: A Software for Population Genetics Data Analysis. 2000, Geneva, University of Geneva, [http:\/\/anthro.unige.ch\/arlequin]2.000","edition":"2.000"},{"key":"162_CR24","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1002\/art.20877","volume":"52","author":"A Barton","year":"2005","unstructured":"Barton A, Eyre S, Bowes J, Ho P, John S, Worthington J: Investigation of the SLC22A4 gene (associated with rheumatoid arthritis in a Japanese population) in a United Kingdom population of rheumatoid arthritis patients. Arthritis Rheum. 2005, 52: 752-758. 10.1002\/art.20877.","journal-title":"Arthritis Rheum"},{"key":"162_CR25","first-page":"842","volume":"33","author":"A Martinez","year":"2006","unstructured":"Martinez A, Valdivia A, Pascual-Salcedo D, Balsa A, Fernandez-Gutierrez B, De la Concha E, Urcelay E: Role of SLC22A4, SLC22A5, and RUNX1 genes in rheumatoid arthritis. J Rheumatol. 2006, 33: 842-846.","journal-title":"J Rheumatol"},{"key":"162_CR26","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/sj.ejhg.5201529","volume":"14","author":"A Martinez","year":"2006","unstructured":"Martinez A, Del Carmen Martin M, Mendoza JL, Taxonera C, Diaz-Rubio M, de la Concha EG, Urcelay E: Association of the organic cation transporter OCTN genes with Crohn's disease in the Spanish population. Eur J Hum Genet. 2006, 14: 222-226. 10.1038\/sj.ejhg.5201529.","journal-title":"Eur J Hum Genet"},{"key":"162_CR27","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1086\/324341","volume":"69","author":"J Nerup","year":"2001","unstructured":"Nerup J, Pociot F: A genomewide scan for type 1-diabetes susceptibility in Scandinavian families: identification of new loci with evidence of interactions. Am J Hum Genet. 2001, 69: 1301-13. Epub 2001 Oct 11.. 10.1086\/324341.","journal-title":"Am J Hum Genet"},{"key":"162_CR28","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.2337\/diabetes.51.5.1609","volume":"51","author":"CM Lindgren","year":"2002","unstructured":"Lindgren CM, Widen E, Tuomi T, Li H, Almgren P, Kanninen T, Melander O, Weng J, Lehto M, Groop LC: Contribution of known and unknown susceptibility genes to early-onset diabetes in scandinavia: evidence for heterogeneity. Diabetes. 2002, 51: 1609-1617.","journal-title":"Diabetes"},{"key":"162_CR29","unstructured":"UCLA Department of Statistics. [http:\/\/calculatorsstatuclaedu\/powercalc]."},{"key":"162_CR30","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/ng1001-229","volume":"29","author":"MJ Daly","year":"2001","unstructured":"Daly MJ, Rioux JD, Schaffner SF, Hudson TJ, Lander ES: High-resolution haplotype structure in the human genome. Nat Genet. 2001, 29: 229-232. 10.1038\/ng1001-229.","journal-title":"Nat Genet"}],"container-title":["BMC Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2350-7-54.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2350-7-54\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2350-7-54","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2350-7-54.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:30:12Z","timestamp":1630456212000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenet.biomedcentral.com\/articles\/10.1186\/1471-2350-7-54"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6,23]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["162"],"URL":"https:\/\/doi.org\/10.1186\/1471-2350-7-54","relation":{},"ISSN":["1471-2350"],"issn-type":[{"value":"1471-2350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,6,23]]},"assertion":[{"value":"11 April 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2006","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2006","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"54"}}